A 62-year-old female patient with a history of type 1 diabetes mellitus, obesity, and hypertension developed fixed drug eruption following semaglutide administration, representing the first reported case of this reaction to the glucagon-like peptide-1 receptor agonist, according to researchers at Temple University Lewis Katz School of Medicine
MMTT was performed in 3 days after 25 mg daily of alogliptin was changed to 0.75 mg weekly of dulaglutide, leaving the other antidiabetic drugs and insulin glargine unchanged
Loss of kisspeptin signaling causes hypogonadotrophic hypogonadism in humans and other mammals. Key findings from human studies include: For a full review of the science, see the PMC comprehensive review on kisspeptin and reproductive disorders
The main channel for this first campaign is Instagram, due to the high volume of conversations and information on GLP-1 receptor agonists circulating on this platform, the EMA said
Learn more: Dupixent dosages by condition Side effects of Dupixent may vary depending on the condition the drug is being used to manage and other factors, such as: your age other health conditions you have other medications you may be taking The most common side effects of Dupixent reported in clinical studies of the drug for its FDA-approved uses included: injection site reactions conjunctivitis blepharitis keratitis dry eyes oral herpes (cold sores) and other herpes simplex virus infections insomnia muscle or joint pain Note: This list does not include all of the more common side effects of Dupixent
